Skip to main content
. 2026 Apr 24;17:1801603. doi: 10.3389/fphar.2026.1801603

FIGURE 1.

Flowchart illustrating participant progression in a randomized study with 186 assessed for eligibility, 6 excluded, 180 randomized equally to two groups, no loss to follow-up or discontinued interventions, and all analyzed for outcomes.

CONSORT flow diagram of the study. Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; Group D+M, received intranasal dexmedetomidine combined with oral midazolam; Group D+C, received intranasal dexmedetomidine combined with oral chloral hydrate.